HIMSS, PCHAlliance Comment on FDA Proposed Regulatory Framework for Changes to Artificial Intelligence/Machine Learning

HIMSS and PCHAlliance submitted a joint comment to the FDA in response to its recent discussion paper and request for feedback on a Proposed Regulatory Framework for Modifications to AI/ML-Based Software as a Medical Device.

Read the full post on HIMSS News